| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.007 | 0.8 |